Is a complete LNAI research report available?

No complete published report is available for Lunai Bioworks Inc. (LNAI) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Lunai Bioworks Inc. (LNAI)

NASDAQ: LNAI · USD

$2.33

+0.01 (+0.4%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-25 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first LNAI analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	10.6M
Revenue (ttm)	20.9K
Net income (ttm)	-128.3M
EPS (ttm)	-$46.2
Shares out	4.5M
Volume	12,878.882
Beta	0.35

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 20.9K
Net income (ttm): -128.3M
EPS (ttm): -$46.2
Market cap: 10.6M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	27.4B	36.9x	5.7x	96.6%	+47.5%	-37.8%	Strong Buy
ARGX	argenx SE	53.8B	31.3x	10.1x	50.6%	+58.8%	+45.7%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All LNAI indicators

Market & fundamental data

Available fields

183

Groups with data

Currency

USD

Showing 183 of 183 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001527728
Company name	Lunai Bioworks Inc.
Country	United States
Country code	US
Cusip	29350E302
Employees	29
Employees Change	4%
Employees Change Percent	16
Enterprise value	$8.8M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
Isin	US29350E3027
Last refreshed	2026-07-25
Market cap	$10.6M
Market cap category	Nano-Cap
Price	$2.33
Price currency	USD
Rev Per Employee	722.14x
Sector	Healthcare
Sector PE	44.87
Sector PE Fwd	23.76
Symbol	LNAI
Website	https://www.lunaibioworks.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-1,214.36%
EV/Sales	421.17x
FCF yield	-49.79%
P/S ratio	504.44x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-637,607.08%
EBITDA Margin	-637,105.86%
Gross margin	100%
Gross Profit	$20,942
Net Income	$-128.3M
Net Income Growth Years	0%
Pretax Margin	-612,568.11%
Profit Per Employee	$-4.4M
ROA	-9.65
Roa5y	-12.9
ROCE	1,417.2
ROE	-325.5
Roe5y	-119
ROIC	-14.02

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-91.45%
Cagr3y	-62.22%
Cagr5y	-64.17%
EPS Growth Years	0
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0
Assets	$9.9M
Cash	$3.2M
Current Assets	$3.7M
Current Liabilities	$19.3M
Debt	$1.4M
Equity	$-9.6M
Interest Coverage	-247.3
Liabilities	$19.4M
Long Term Assets	$6.1M
Long Term Liabilities	$131,316
Net Cash	$1.7M
Net Cash By Market Cap	$16.51
Tangible Book Value	$-15.6M
Tangible Book Value Per Share	$-3.5
WACC	9.03

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.19
Net Working Capital	$-17.4M
Quick ratio	0.16
Working Capital	$-15.6M
Working Capital Turnover	$-0

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-39.92%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-91.44%
200-day SMA	5.26
3Y total return	-94.61%
50-day SMA	2.8
50-day SMA vs 200-day SMA	50under200
5Y total return	-99.41%
All Time High	1,102.4
All Time High Change	-99.79%
All Time High Date	2021-12-01
All Time Low	1.21
All Time Low Change	92.56%
All Time Low Date	2026-03-12
ATR	0.33
Beta	0.35
Beta1y	-0.54
Beta2y	1.59
Ch YTD	-66.97
High	2.52
High52	28
High52 Date	2025-07-28
High52ch	-91.68%
Low	2.32
Low52	1.21
Low52 Date	2026-03-12
Low52ch	92.56%
Ma50ch	-16.82%
Premarket Change Percent	-0.43
Premarket Price	$2.31
Premarket Volume	3,891
Price vs 200-day SMA	-55.71%
RSI	37.96
RSI Monthly	37.73
RSI Weekly	35.4
Sharpe ratio	-0.31x
Sortino ratio	-0.64
Total Return	-39.92%
Tr YTD	-66.97
Tr1m	-45.81%
Tr1w	-17.38%
Tr3m	-4.41%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	$-9.8M
Operating margin	-47,019.4

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	3,170,448%
Float Percent	69.93%
Net Borrowing	3,925,675
Shares Insiders	23.59%
Shares Institutions	2.72%
Shares Out	4,533,889
Shares Qo Q	6.44%
Shares Yo Y	39.92%
Short Float	4.74%
Short Ratio	0.06
Short Shares	3.31

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-6.9M
Average Volume	53,940.75x
Bv Per Share	-2.14
CAPEX	$-1,238
Ch1m	-45.81
Ch1w	-17.38
Ch1y	-91.44
Ch3m	-4.43
Ch3y	-94.61
Ch5y	-99.41
Ch6m	-66.83
Change	0.43%
Change From Open	-2.51
Close	2.32
Days Gap	3.02
Depreciation Amortization	76,992
Dollar Volume	30,007.8
Earnings Date	2026-05-15
Earnings Time	amc
EBIT	$-133.5M
EBITDA	$-133.4M
EPS	$-46.23
F Score	2
FCF	$-5.3M
FCF EV Yield	-59.63x
FCF Per Share	$-1.16
Financing CF	6,175,226
Fiscal Year End	June
Goodwill	5,963,000
Investing CF	1,507,851
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-15
Last Report Date	2026-03-31
Last Split Date	2026-05-22
Last Split Type	Reverse
Ma150	3.99
Ma150ch	-41.65%
Ma20	2.87
Ma20ch	-18.84%
Net CF	2,232,270
Next Earnings Date	2026-09-28
Open	2.39
Optionable	Yes
Position In Range	5
Post Close	2.33
Postmarket Change Percent	-0.86
Postmarket Price	$2.31
Ppne	12,956
Pre Close	2.32
Price Date	2026-07-24
Relative Volume	0.24x
Revenue	20,942x
SBC By Revenue	7,857.97x
Share Based Comp	1,645,617
Tr6m	-66.83%
Us State	California
Volume	12,878.9
Z Score	-76.7

Lunai Bioworks Inc. (LNAI)

Coverage state: Market snapshot only — no published research

Generate the first LNAI analysis

Price

Financial snapshot

Fair-value bridge

Latest news · LNAI

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All LNAI indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on LNAI

Frequently asked questions